Oct 2026· Cell· Vol 189 21, pp.
6589-6593
· 0 citations· 21 references
Medicine
TL;DR
The SMaHT Network now delivers benchmarked tools and the first body-wide map of somatic mosaicism, establishing a baseline of "normal" against which its roles in development, aging, and disease can finally be tested.
Abstract
Every cell in the human body carries its own genome, shaped by mutations acquired over a lifetime, yet this vast somatic variation has been nearly impossible to measure. The SMaHT Network now delivers benchmarked tools and the first body-wide map of somatic mosaicism, establishing a baseline of "normal" against which its roles in development, aging, and disease can finally be tested.
These studies show that detection performance depends on reference representation, benchmark quality, and experimental design, requiring careful calibration when integrating technologies.
Liu et al. enabled genome-wide clustered regularly interspaced short palindromic repeats (CRISPR) screening of primary human T cells in vivo and identified P2RY8 and GNAS through complementary functional readouts. We discuss how context shapes perturbation effects, and how readouts guide prioritization, with implicatio...
Jie-Liu-Xiao-Hui-Yang-Fan-Zhu-Xue-Dong Zhong, Jia-Jia Wang, Chen Wang et al.· Trends in Cancer· 0 citations
Advances in precision genome editing and increased public support suggest that the field is ready for new clinical and regulatory pathways, including therapeutic germline gene editing.
Africa harbors more genetic variation than the rest of the world combined, but approximately 1% of genomes in major databases derive from individuals of African ancestry. This is not an equity problem; it is a scientific error that distorts drug dosing, degrades risk scores, and undermines precision medicine globally.
Wubalem D. Seifu, Z. E. Bedada, Chang-Qing Zeng· Trends in Genetics· 0 citations
This issue of Cancer Cell, Hyeon et al. identify and map significantly mutated regions to protein domains and structural features, establishing a proteo-genomics framework for interpreting cancer mutations beyond genes and hotspots.